Siegfried (SFZN.SW) launched its new drug substances manufacturing facility in Minden, Germany, according to a Tuesday release.
The petrochemicals company's new facility is equipped with gravity-flow processing and radio frequency identification-enabled recipe management capabilities and expands its active pharmaceutical ingredient manufacturing output with 100 cubic meters of additional reactor capacity.